Thank you very much!

In this chapter, we explore the evolving landscape of substances with abuse potential (including #ketamine and #psychedelics) being repurposed for therapeutic use in #bipolardisorder, highlighting both their promise and the risks involved.

Read more: link.springer.com/chapter/10.1...

This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality. #ADAA2025

I will present preliminary data from our randomized clinical trial (clinicaltrials.gov/study/NCT041...), examining the impact of chronic pain on #ketamine response in treatment-resistant #depression. I look forward to sharing our findings! #suicideprevention

A heartfelt thank you to my collaborators, mentors, research team, and the patients who made this work possible!

Our trial is investigating the efficacy and safety of buprenorphine in prolonging the antisuicidal and antidepressant effects of ketamine (clinicaltrials.gov/study/NCT041...), and the final results are coming soon!

A huge thank you to my mentors, colleagues, and collaborators who have supported my journey. I look forward to engaging with the ISCTM community and contributing to discussions on clinical trial methodology in psychiatry!

The film challenges us to embrace the chaos of difficult times, using them not as reasons to retreat but as fuel to redefine our purpose. In the face of uncertainty, we have the power to turn personal suffering into growth, resilience, and meaningful change.

Science thrives on collaboration, and I'm pleased to have built meaningful connections and gained new perspectives that will inspire my future work.